The Incidence Of Bladder Cancer after Cyclophosphamide Therapy

Authors:

Abstract
The records of 19,082 patients with non-uroepithelial cancers were reviewed to determine the incidence of de novo bladder cancer in patients treated with cyclophosphamide versus patients not treated with this drug. A 9-fold increased incidence of bladder cancer was found in the cyclophosphamide-treated group.

This publication has 14 references indexed in Scilit: